research

Three new studies examine dupilumab and biologic therapy in severe type 2 asthma, adding real-world weight to existing trial evidence.

Stem cell therapy, System Xc- pathway modulation, and Ayurvedic add-on regimens are each being evaluated as neuroprotective strategies in Parkinson's disease.

Three 2026 reviews map the current evidence for ctDNA and liquid biopsy in CRC detection and monitoring, and where integration lags behind the data.

VESALIUS-CV tests evolocumab in diabetic patients without established atherosclerosis, while new trials probe plaque biology and lipid pathways beyond LDL.

A perilla essential oil nanoemulsion reduced erythema, scaling, and inflammatory markers in imiquimod-induced psoriasis, with curcumin co-loading enhancing skin permeation.

A 2026 meta-analysis examines SGLT2 inhibitor use in diabetic heart transplant recipients, a population where evidence has been thin and stakes are high.